Chimerix Investor Conference Presentation Deck slide image

Chimerix Investor Conference Presentation Deck

Progression-Free Survival 19 Survival Probability 1.0 0.8 0.6 0.4 0.2 0.0 0 n 50 3 20 6 13 9 12 Months from First Dose 12 10 6 Months 12 Months 15 PFS (95% CI) 6 18 5 35% (21-49) 30% (17-44) 21 2 24 2
View entire presentation